ALREX

This brand name is authorized in United States. It is also authorized in Brazil, Canada, Hong Kong SAR China, Singapore, South Africa.

Active ingredients

The drug ALREX contains one active pharmaceutical ingredient (API):

1	Loteprednol UNII YEH1EZ96K6 - LOTEPREDNOL ETABONATE
	Loteprednol etabonate is a new class of corticosteroid with potent antiinflammatory activity designed to be active at the site of action. Its antiinflammatory activity is similar to the most powerful steroid used in ophthalmology but with less intraocular pressure.
	Read more about Loteprednol

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ALREX Ophthalmic suspension	MPI, US: SPL/Old	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01BA14	Loteprednol	S Sensory organs → S01 Ophthalmologicals → S01B Antiinflammatory agents → S01BA Corticosteroids, plain
Discover more medicines within S01BA14

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	503100801176418
CA	Health Products and Food Branch	02320924
HK	Department of Health Drug Office	54255
SG	Health Sciences Authority	13427P
US	FDA, National Drug Code	24208-353
ZA	Health Products Regulatory Authority	38/15.2/0203